Jan Cools

21.5k citations
185 papers · 8.5k · h-index 55

Impact in

  • Hematology top 0.2%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

Co-authors
Peter Marynen (47 shared papers)Nicole Mentens (31 shared papers)Iwona Włodarska (36 shared papers)Peter Vandenberghe (40 shared papers)Kim De Keersmaecker (26 shared papers)D. Gary Gilliland (9 shared papers)Carmen Vicente (15 shared papers)Jason Gotlib (2 shared papers)
Journals
Blood (44 papers)Haematologica (29 papers)Leukemia (19 papers)Genes Chromosomes and Cancer (5 papers)Cancer Research (5 papers)
Partner nations
BelgiumUnited StatesFrance

In The Last Decade

Jan Cools

179 papers receiving 8.3k citations

Peers

Jan Cools
Comparison fields: 5 of 131
  • Hematology 2.8k
  • Genetics 1.5k
  • Rheumatology 1.8k
  • Gastroenterology 570
  • Immunology 1.5k
Replace Ulrich Jaeger with:
Ulrich Jaeger Austria
Bertil Johansson Sweden
Letizia Foroni United Kingdom
Berthold Streubel Austria
Lucienne Michaux Belgium
Javier Pinilla‐Ibarz United States
Ulrich Dührsen Germany
Lidia Larizza Italy
Takuro Nakamura Japan
Wolf‐Karsten Hofmann Germany
Jan Cools relative to Ulrich Jaeger Austria Ulrich Jaeger's profile →
Citations per field
00.5×2×4×5.9×
Ulrich Jaeger · 1×
Citations per year

Countries citing papers authored by Jan Cools

Since Specialization
Citations

This map shows the geographic impact of Jan Cools's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Cools with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Cools more than expected).

Fields of papers citing papers by Jan Cools

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Cools. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Cools. The network helps show where Jan Cools may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Cools, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Cools Line = papers co-authored together Jan Cools links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
Gastroenterology ·Maria Dêbiec‐Rychter, Jan Cools, Herlinde Dumez, Raf Sciot, Michel Stul, Nicole Mentens, Hilde Vranckx, Bartosz Wasąg, Hans Prenen, Johannes Roesel, Anne Hagemeijer, A. van Oosterom, Peter Marynen
2005396
2
Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia
Blood ·Pieter J. Peeters, Sophie Raynaud, Jan Cools, Iwona Włodarska, Josiane Grosgeorge, Patrick Philip, Fabrice Monpoux, Luc Van Rompaey, Mathijs Baens, Herman Van den Berghe, Peter Marynen
1997393
3
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
Nature Genetics ·Hilde Brems, Magdalena Chmara, Mourad Sahbatou, Ellen Denayer, Koji Taniguchi, Reiko Kato, Riet Somers, Ludwine Messiaen, Sofie De Schepper, Jean‐Pierre Fryns, Jan Cools, Peter Marynen, Gilles Thomas, Akihiko Yoshimura, Eric Legius
2007291
4
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness
Blood ·Amy D. Klion, Pierre Noël, Cem Akin, Melissa Law, D. Gary Gilliland, Jan Cools, Dean D. Metcalfe, Thomas B. Nutman
2003280
5
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
Blood ·Animesh Pardanani, Rhett P. Ketterling, Stephanie R. Brockman, Heather C. Flynn, Sarah F. Paternoster, Brandon M. Shearer, Terra L. Reeder, Chin‐Yang Li, Nicholas C.P. Cross, Jan Cools, D. Gary Gilliland, Gordon W. Dewald, Ayalew Tefferi
2003269
6
Efficacy of the Kinase Inhibitor SU11248 against Gastrointestinal Stromal Tumor Mutants Refractory to Imatinib Mesylate
Clinical Cancer Research ·Hans Prenen, Jan Cools, Nicole Mentens, Cedric Folens, Raf Sciot, Patrick Schöffski, A. van Oosterom, Peter Marynen, Maria Dêbiec‐Rychter
2006226
7
The genetics and molecular biology of T-ALL
Blood ·Tiziana Girardi, Carmen Vicente, Jan Cools, Kim De Keersmaecker
2017226
8
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor
Genes Chromosomes and Cancer ·Jan Cools, Iwona Włodarska, Riet Somers, Nicole Mentens, Florence Pédeutour, Brigitte Maes, Christiane De Wolf‐Peeters, Patrick Pauwels, Anne Hagemeijer, Peter Marynen
2002210
9
Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia
Nature Genetics ·Idoya Lahortiga, Kim De Keersmaecker, Pieter Van Vlierberghe, Carlos Graux, Barbara Cauwelier, Frédéric Lambert, Nicole Mentens, H. Berna Beverloo, Rob Pieters, Frank Speleman, María D. Odero, Marijke Bauters, Guy Froyen, Peter Marynen, Peter Vandenberghe, Iwona Włodarska, Jules P.P. Meijerink, Jan Cools
2007197
10
The FIP1L1-PDGFRα fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
Blood ·Jason Gotlib, Jan Cools, James Malone, Stanley L. Schrier, D. Gary Gilliland, Steven Coutré
2003182
11
Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast
Leukemia ·Carlos Graux, Jan Cools, Lucienne Michaux, Peter Vandenberghe, A Hagemeijer
2006170
12
The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia
Blood ·Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, Charles Lee, H. Berna Beverloo, Peter J. van der Spek, Andrew Stubbs, Jan Cools, Kyosuke Nagata, Maarten Fornerod, Jessica G. C. A. M. Buijs-Gladdines, Martin A. Horstmann, Elisabeth R. van Wering, Jean Soulier, Rob Pieters, Jules P.P. Meijerink
2008158
13
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
Nature Genetics ·Maria Kleppe, Idoya Lahortiga, Tiama El Chaar, Kim De Keersmaecker, Nicole Mentens, Carlos Graux, Katrien Van Roosbroeck, Adolfo A. Ferrando, Anton W. Langerak, Jules P.P. Meijerink, François Sigaux, Torsten Haferlach, Iwona Włodarska, Peter Vandenberghe, Jean Soulier, Jan Cools
2010141
14
Prediction of Resistance to Small Molecule FLT3 Inhibitors
Cancer Research ·Jan Cools, Nicole Mentens, Pascal Furet, Doriano Fabbro, Jennifer Clark, James D. Griffin, Peter Marynen, D. Gary Gilliland
2004141
15
PHF6 mutations in adult acute myeloid leukemia
Leukemia ·Pieter Van Vlierberghe, Jay Patel, Omar Abdel‐Wahab, Camille Lobry, Cyrus V. Hedvat, Milagros Balbı́n, Carlos Nicolás, Ángel Ramírez Páyer, Hugo F. Fernández, Martin S. Tallman, Elisabeth Paietta, Ari Melnick, Peter Vandenberghe, Frank Speleman, Iannis Aifantis, Jan Cools, Ross L. Levine, Adolfo A. Ferrando
2010124
16
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
Leukemia ·Peter Vandenberghe, Iwona Włodarska, Lucienne Michaux, Pierre Zachée, M. Boogaerts, Danny Vanstraelen, M.-C Herregods, A Van Hoof, Dominik Selleslag, Florence Roufosse, Marie Maerevoet, G. Verhoef, Jan Cools, D. Gary Gilliland, A Hagemeijer, Peter Marynen
2004116
17
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis
Blood ·Zhigui Ma, Jan Cools, Peter Marynen, Xiaoli Cui, Reiner Siebert, Stefan Gesk, Brigitte Schlegelberger, Benjamin Peeters, Christiane De Wolf‐Peeters, Iwona Włodarska, Stephan W. Morris
2000116
18
Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia
Haematologica ·Carmen Vicente, Claire Schwab, Michaël Broux, Ellen Geerdens, Sandrine Degryse, Sofie Demeyer, Idoya Lahortiga, Alfred M. Elliott, Lucy Chilton, Roberta La Starza, Cristina Mecucci, Peter Vandenberghe, Nicholas Goulden, Ajay Vora, Anthony V. Moorman, Jean Soulier, Christine J. Harrison, Emmanuelle Clappier, Jan Cools
2015113
19
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
Blood ·Sandrine Degryse, Charles E. de Bock, Luk Cox, Sofie Demeyer, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Valentina Gianfelici, Gert Hulselmans, Mark Fiers, Stein Aerts, Jules P.P. Meijerink, Thomas Tousseyn, Jan Cools
2014109
20
Five years since the discovery of FIP1L1–PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias
Leukemia ·Jason Gotlib, Jan Cools
2008102

About Jan Cools

Jan Cools is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Rheumatology and Immunology, having authored 185 papers that have together received 8.5k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (72 papers), Acute Lymphoblastic Leukemia research (50 papers), Acute Myeloid Leukemia Research (43 papers), Eosinophilic Disorders and Syndromes (42 papers), Lymphoma Diagnosis and Treatment (25 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers). The work is most often cited by research in Hematology (2.8k citations), Genetics (1.5k citations), Rheumatology (1.8k citations), Gastroenterology (570 citations) and Immunology (1.5k citations). Jan Cools has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Peter Marynen, Nicole Mentens, Iwona Włodarska, Peter Vandenberghe, Kim De Keersmaecker, D. Gary Gilliland, Carmen Vicente, Jason Gotlib, Maria Dêbiec‐Rychter and Anne Hagemeijer. Their work appears in journals such as Blood, Haematologica, Leukemia, Genes Chromosomes and Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich JaegerBreakdown of academic impact, for papers by Bertil JohanssonBreakdown of academic impact, for papers by Letizia ForoniBreakdown of academic impact, for papers by Berthold StreubelBreakdown of academic impact, for papers by Lucienne MichauxBreakdown of academic impact, for papers by Javier Pinilla‐IbarzBreakdown of academic impact, for papers by Ulrich DührsenBreakdown of academic impact, for papers by Lidia LarizzaBreakdown of academic impact, for papers by Takuro NakamuraBreakdown of academic impact, for papers by Wolf‐Karsten Hofmann